Seeing Is Believing

Currently out of the existing stock ratings of Dan Leonard, 255 are a BUY (63.91%), 122 are a HOLD (30.58%), 22 are a SELL (5.51%).
Analyst Dan Leonard, currently employed at RBC, carries an average stock price target met ratio of 65.93% that have a potential upside of 17.26% achieved within 258 days. Previously, Dan Leonard worked at WELLS FARGO, UBS.
Dan Leonard’s has documented 812 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on DHR, Danaher.
Analyst best performing recommendations are on ADPT (ADAPTIVE BIOTECHNOLOGIES CORP).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 2/25/2026. The price target of $175 was fulfilled within 1 day with a profit of $7.44 (4.44%) receiving and performance score of 44.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Nov-2025
$185
$17.22 (10.26%)
$155
1 months 9 days ago
(27-Aug-2026)
26/29 (89.66%)
$27.31 (17.32%)
406
Buy Since 27-Aug-2026
$180
$12.22 (7.28%)
$128
1 months 9 days ago
(27-Aug-2026)
2/3 (66.67%)
$22.31 (14.15%)
81
Buy Since 09-Oct-2025
$190
$22.22 (13.24%)
$180
1 months 9 days ago
(27-Aug-2026)
1/3 (33.33%)
$32.31 (20.49%)
348
Buy Since 06-Apr-2026
$172
$4.22 (2.52%)
$148
1 months 9 days ago
(27-Aug-2026)
14/14 (100%)
$14.31 (9.07%)
142
Buy Since 22-Aug-2024
$190
$22.22 (13.24%)
$185
1 months 9 days ago
(27-Aug-2026)
23/26 (88.46%)
$32.31 (20.49%)
311
Which stock is Dan Leonard most bullish on?
Which stock is Dan Leonard most reserved on?
What Year was the first public recommendation made by Dan Leonard?